SciSparc (SPRC) News Today → Crypto Millionaire Says: “Buy This $11 AI Coin.” (From InvestorPlace) (Ad) Free SPRC Stock Alerts $1.25 0.00 (0.00%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 13, 2024 | investing.comSciSparc to acquire AutoMax in strategic mergerApril 11, 2024 | finanznachrichten.deSciSparc Ltd: SciSparc to Acquire AutoMaxApril 11, 2024 | msn.comSciSparc to acquire vehicle importer AutoMaxApril 11, 2024 | msn.comSciSparc To Acquire AutoMax, A Strategic Leap Towards Industry DiversificationApril 11, 2024 | globenewswire.comSciSparc to Acquire AutoMaxMarch 27, 2024 | globenewswire.comSciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating DepressionMarch 23, 2024 | finanznachrichten.deSciSparc Ltd: SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer ResearchMarch 21, 2024 | globenewswire.comSciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer ResearchMarch 18, 2024 | globenewswire.comSciSparc Granted Another Patent, Strengthening its Core Technology in CanadaMarch 14, 2024 | investing.comSciSparc's venture MitoCareX Bio advances AI model for cancer drug discoveryMarch 14, 2024 | globenewswire.comSciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical TrialMarch 12, 2024 | globenewswire.comSciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule StructureMarch 8, 2024 | msn.comAutism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New TreatmentsMarch 8, 2024 | finanznachrichten.deSciSparc Ltd: SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum DisorderMarch 8, 2024 | globenewswire.comSciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum DisorderMarch 7, 2024 | finanznachrichten.deSciSparc Ltd: SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management TechnologyMarch 7, 2024 | globenewswire.comSciSparc Granted Patent for Core Technology in Multiple Jurisdictions in EuropeMarch 6, 2024 | globenewswire.comSciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management TechnologyFebruary 29, 2024 | globenewswire.comSciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of DosingFebruary 27, 2024 | msn.comSciSparc gains as Clearmind partnership yields 3 new international patent applicationsFebruary 27, 2024 | globenewswire.comSciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine CompoundsFebruary 21, 2024 | msn.comSciSparc shares up on patents filed for psychedelic compounds with ClearmindFebruary 20, 2024 | marketbeat.comTrading was temporarily halted for "SPRC" at 09:02 AM with a stated reason of "LULD pause."February 20, 2024 | globenewswire.comSciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based CompoundsFebruary 1, 2024 | benzinga.comSciSparc Stock (NASDAQ:SPRC), Analyst Ratings, Price Targets, PredictionsJanuary 29, 2024 | finance.yahoo.comSciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum DisorderJanuary 24, 2024 | investorplace.comWhy Is SciSparc (SPRC) Stock Up 50% Today?January 24, 2024 | marketbeat.comTrading was temporarily halted for "SPRC" at 10:01 AM with a stated reason of "LULD pause."January 24, 2024 | marketbeat.comTrading was temporarily halted for "SPRC" at 10:01 AM with a stated reason of "LULD pause."January 24, 2024 | finance.yahoo.comSciSparc Ltd. Announces $20 Million Standby Equity Purchase AgreementJanuary 24, 2024 | marketbeat.comTrading was temporarily halted for "SPRC" at 09:01 AM with a stated reason of "LULD pause."January 19, 2024 | finance.yahoo.comSciSparc Advances the Acquisition Process of a Leading Vehicle Importer Company in Israel with the provision of a Bridge Loan of $1.4 millionJanuary 4, 2024 | stockhouse.comClearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based TreatmentsJanuary 4, 2024 | finance.yahoo.comSciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based TreatmentsDecember 15, 2023 | msn.comSciSparc stock jumps 25% amid MitoCare X Bio investmentDecember 13, 2023 | msn.comWhy Is SciSparc (SPRC) Stock Up 25% Today?December 7, 2023 | finance.yahoo.comSciSparc Provides Updates Regarding the Non-Binding Letter of Intent to Acquire Leading Vehicle Importer Company in IsraelDecember 1, 2023 | finance.yahoo.comWeight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical TrialNovember 28, 2023 | msn.comClearmind, SciSparc slide amid weight-loss study resultsNovember 28, 2023 | msn.comSciSparc stock slides 12% amid shareholder rights plan, study resultsNovember 28, 2023 | finance.yahoo.comSciSparc Adopts Limited Duration Shareholder Rights PlanNovember 27, 2023 | msn.comWhat's Going On With SciSparc Shares Today?November 27, 2023 | finance.yahoo.comSciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery PlatformNovember 24, 2023 | msn.comSciSparc initiates clinical study of CBD-based drug for autism symptomsNovember 24, 2023 | msn.comWhy SciSparc Ltd Stock Is Blasting HigherNovember 24, 2023 | finance.yahoo.comNew Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum DisorderNovember 24, 2023 | marketbeat.comTrading was temporarily halted for "SPRC" at 10:11 AM with a stated reason of "LULD pause."November 22, 2023 | markets.businessinsider.comSciSparc Reveals Non-Binding LoI To Merge With Vehicle Importer In IsraelNovember 22, 2023 | markets.businessinsider.comGold Moves Lower; SciSparc Shares Spike HigherNovember 22, 2023 | msn.comWhy SciSparc Stock Is Trading Higher Wednesday Get SciSparc News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRC and its competitors with MarketBeat's FREE daily newsletter. Email Address Guard Against the Coming Financial Upheaval (Ad)America’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late. You can stream it for free right here. SPRC Media Mentions By Week SPRC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SPRC News Sentiment▼1.440.57▲Average Medical News Sentiment SPRC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SPRC Articles This Week▼22▲SPRC Articles Average Week Get SciSparc News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EVFM News EVLO News SBFM News BLPH News HSTO News CMRA News SXTC News APVO News TMBR News ADTX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SPRC) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressNo experience to confident trader, meet my student…Wealth Builders InstituteThe only AI company you should be looking atBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SciSparc Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
